Journal of Vascular Surgery
Volume 52, Issue 1 , Pages 55-61.e2 , July 2010

An analysis of drug modulation of abdominal aortic aneurysm growth through 25 years of surveillance

  • Andrew Thompson, MD, FRCS

      Affiliations

    • Vascular Surgery Department, Western Sussex Hospitals NHS Trust, Chichester, United Kingdom
    • Cardiovascular Genetics Department, University College London, London, United Kingdom
    • ,
  • Jackie A. Cooper, MSc

      Affiliations

    • Cardiovascular Genetics Department, University College London, London, United Kingdom
    • ,
  • Michael Fabricius, MB BS

      Affiliations

    • Vascular Surgery Department, Western Sussex Hospitals NHS Trust, Chichester, United Kingdom
    • ,
  • Steve E. Humphries, PhD, MRCP, FRCPath

      Affiliations

    • Cardiovascular Genetics Department, University College London, London, United Kingdom
    • ,
  • Hilary A. Ashton, MSc

      Affiliations

    • Vascular Surgery Department, Western Sussex Hospitals NHS Trust, Chichester, United Kingdom
    • ,
  • Hany Hafez, PhD, FRCS

      Affiliations

    • Vascular Surgery Department, Western Sussex Hospitals NHS Trust, Chichester, United Kingdom
    • Corresponding Author InformationReprint requests: H. Hafez, Consultant Vascular Surgeon, St. Richards Hospital, Western Sussex Hospitals NHS Trust, Spitalfield Lane, Chichester PO19 6SE, UK

Received 12 September 2009 ,Accepted 3 February 2010.

References 

  1. Ashton H, Buxton MJ, Day NE, Kim LG, Marteau TM, Scott RA, et al. The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet. 2002;360:1531–1539
  2. Lederle FA, Wilson SE, Johnson GR, Reinke DB, Littooy FN, Acher CW, et al. Immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med. 2002;346:1437–1444
  3. Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms (The UK Small Aneurysm Trial Participants). Lancet. 1998;352:1649–1655
  4. Thompson AR, Cooper JA, Ashton HA, Hafez H. Growth rates of small abdominal aortic aneurysms correlate with clinical events. Br J Surg. 2010;97:37–44
  5. Golledge J, Powell JT. Medical management of abdominal aortic aneurysm. Eur J Vasc Endovasc Surg. 2007;34:267–273
  6. Choke E, Cockerill G, Wilson WR, Sayed S, Dawson J, Loftus I, et al. A review of biological factors implicated in abdominal aortic aneurysm rupture. Eur J Vasc Endovasc Surg. 2005;30:227–244
  7. Baxter BT, Terrin MC, Dalman RL. Medical management of small abdominal aortic aneurysms. Circulation. 2008;117:1883–1889
  8. Hackam DG, Thiruchelvam D, Redelmeier DA. Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study. Lancet. 2006;368:659–665
  9. Brady AR, Thompson SG, Fowkes FG, Greenhalgh RM, Powell JT. Abdominal aortic aneurysm expansion: risk factors and time intervals for surveillance. Circulation. 2004;110:16–21
  10. Browne WJ. MCMC Estimation in MLwiN, v2.10. Centre for Multilevel Modelling, University of Bristol; 2009;
  11. Mofidi R, Goldie VJ, Kelman J, Dawson AR, Murie JA, Chalmers RT. Influence of sex on expansion rate of abdominal aortic aneurysms. Br J Surg. 2007;94:310–314
  12. Solberg S, Singh K, Wilsgaard T, Jacobsen BK. Increased growth rate of abdominal aortic aneurysms in women (The Tromso study). Eur J Vasc Endovasc Surg. 2005;29:145–149
  13. Santilli SM, Littooy FN, Cambria RA, Rapp JH, Tretinyak AS, d'Audiffret AC, et al. Expansion rates and outcomes for the 3.0-cm to the 3.9-cm infrarenal abdominal aortic aneurysm. J Vasc Surg. 2002;35:666–671
  14. Gomez R, Estallo L, Rodriguez L, Baquer M, Barba A. Growth rate and associated factors in small abdominal aortic aneurysms. Vega dC Eur J Vasc Endovasc Surg. 2006;31:231–236
  15. Daugherty A, Manning MW, Cassis LA. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest. 2000;105:1605–1612
  16. Cassis LA, Helton MJ, Howatt DA, King VL, Daugherty A. Aldosterone does not mediate angiotensin II-induced atherosclerosis and abdominal aortic aneurysms. Br J Pharmacol. 2005;144:443–448
  17. Lu H, Rateri DL, Cassis LA, Daugherty A. The role of the renin-angiotensin system in aortic aneurysmal diseases. Curr Hypertens Rep. 2008;10:99–106
  18. Sukhija R, Aronow WS, Sandhu R, Kakar P, Babu S. Mortality and size of abdominal aortic aneurysm at long-term follow-up of patients not treated surgically and treated with and without statins. Am J Cardiol. 2006;97:279–280
  19. Schouten O, van Laanen JH, Boersma E, Vidakovic R, Feringa HH, Dunkelgrun M, et al. Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth. Eur J Vasc Endovasc Surg. 2006;32:21–26
  20. Perneger TV. What's wrong with Bonferroni adjustments. BMJ. 1998;316:1236–1238
  21. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology. 1990;1:43–46

 Competition of interest: none.

 Additional material for this article may be found online at www.jvascsurg.org.

 The editors and reviewers of this article have no relevant financial relationships to disclose per the JVS policy that requires reviewers to decline review of any manuscript for which they may have a competition of interest.

PII: S0741-5214(10)00307-1

doi: 10.1016/j.jvs.2010.02.012

Journal of Vascular Surgery
Volume 52, Issue 1 , Pages 55-61.e2 , July 2010

Article Tools

* Image Usage & Resolution